Network Meta-Analysis of Randomized Trials Evaluating the Comparative Efficacy of Lipid-Lowering Therapies Added to Maximally Tolerated Statins for the Reduction of Low-Density Lip...

by Toth, Peter P, Bray, Sarah, Villa, Guillermo, Palagashvili, Tamara, Sattar, Naveed, Stroes, Erik S G, Worth, Gavin M
Published in Journal of the American Heart Association

Ten things to know about ten cardiovascular disease risk factors

by Bays, Harold E., Taub, Pam R., Epstein, Elizabeth, Michos, Erin D., Ferraro, Richard A., Bailey, Alison L., Kelli, Heval M., Ferdinand, Keith C., Echols, Melvin R., Weintraub, Howard, Bostrom, John, Johnson, Heather M., Hoppe, Kara K., Shapiro, Michael D., German, Charles A., Virani, Salim S., Hussain, Aliza, Ballantyne, Christie M., Agha, Ali M., Toth, Peter P.
Published in American journal of preventive cardiology

Continuity of care and outpatient management for patients with and at high risk for cardiovascular disease during the COVID-19 pandemic: A scientific statement from the American So...

by Khera, Amit, Baum, Seth J., Gluckman, Ty J., Gulati, Martha, Martin, Seth S., Michos, Erin D., Navar, Ann Marie, Taub, Pam R., Toth, Peter P., Virani, Salim S., Wong, Nathan D., Shapiro, Michael D.
Published in American journal of preventive cardiology

Editorial commentary: Is it really a slam-dunk that reducing Lp(a) will decrease risk for cardiovascular events? Not so fast

by Toth, Peter P.
Published in Trends in cardiovascular medicine

That Myalgia of Yours Is Not From Statin Intolerance

by Toth, Peter P
Published in Journal of the American College of Cardiology

Should low high-density lipoprotein cholesterol (HDL-C) be treated?

by Toth, Peter P., M.D., Ph.D, Barylski, Marcin, M.D., Ph.D, Nikolic, Dragana, MD, Rizzo, Manfredi, MD, PhD, Montalto, Giuseppe, MD, Banach, Maciej, MD
Published in Best Practice & Research Clinical Endocrinology & Metabolism

Physical activity, cardiorespiratory fitness, and cardiovascular health: A clinical practice statement of the American Society for Preventive Cardiology Part II: Physical activity,...

by Franklin, Barry A., Eijsvogels, Thijs M.H., Pandey, Ambarish, Quindry, John, Toth, Peter P.
Published in American journal of preventive cardiology

Systematic Review of Low‐Density Lipoprotein Cholesterol Apheresis for the Treatment of Familial Hypercholesterolemia

by Wang, Anthony, Richhariya, Akshara, Gandra, Shravanthi R., Calimlim, Brian, Kim, Lisa, Quek, Ruben G. W., Nordyke, Robert J., Toth, Peter P.
Published in Journal of the American Heart Association

Cardiovascular Risk and Statin Therapy Considerations in Women

by Gheorghe, Gina, Toth, Peter P., Bungau, Simona, Behl, Tapan, Ilie, Madalina, Pantea Stoian, Anca, Bratu, Ovidiu Gabriel, Bacalbasa, Nicolae, Rus, Marius, Diaconu, Camelia Cristina
Published in Diagnostics (Basel)

Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease

by Toth, Peter P
Published in Vascular health and risk management

High-Sensitivity C-Reactive Protein Discordance With Atherogenic Lipid Measures and Incidence of Atherosclerotic Cardiovascular Disease in Primary Prevention: The ARIC Study

by Quispe, Renato, Michos, Erin D, Martin, Seth S, Puri, Rishi, Toth, Peter P, Al Suwaidi, Jassim, Banach, Maciej, Virani, Salim S, Blumenthal, Roger S, Jones, Steven R, Elshazly, Mohamed B
Published in Journal of the American Heart Association

Low-Density Lipoprotein Cholesterol Treatment Rates in High Risk Patients: More Disappointment Despite Ever More Refined Evidence-Based Guidelines

by Toth, Peter P.
Published in American journal of preventive cardiology

Emerging therapies for raising high-density lipoprotein cholesterol (HDL-C) and augmenting HDL particle functionality

by Barylski, Marcin, MD, PhD, Toth, Peter P., MD, PhD, Nikolic, Dragana, MD, Banach, Maciej, MD, Rizzo, Manfredi, MD, PhD, Montalto, Giuseppe, MD
Published in Best Practice & Research Clinical Endocrinology & Metabolism

Treatment of Dyslipidemia in Elderly Patients With Coronary Heart Disease

by Toth, Peter P., MD, PhD
Published in Journal of the American College of Cardiology

Association of statin use in older people primary prevention group with risk of cardiovascular events and mortality: a systematic review and meta-analysis of observational studies

by Awad, Kamal, Mohammed, Maged, Zaki, Mahmoud Mohamed, Abushouk, Abdelrahman I, Lip, Gregory Y. H, Blaha, Michael J, Lavie, Carl J, Toth, Peter P, Jukema, J. Wouter, Sattar, Naveed, Banach, Maciej
Published in BMC medicine

Beyond cardiovascular medicine: potential future uses of icosapent ethyl

by Bhatt, Deepak L, Hull, Mark A, Song, Mingyang, Van Hulle, Carol, Carlsson, Cindy, Chapman, M John, Toth, Peter P
Published in European Heart Journal Supplements

Systematic Review and Network Meta‐Analysis on the Efficacy of Evolocumab and Other Therapies for the Management of Lipid Levels in Hyperlipidemia

by Toth, Peter P., Worthy, Gillian, Gandra, Shravanthi R., Sattar, Naveed, Bray, Sarah, Cheng, Lung‐I., Bridges, Ian, Worth, Gavin M., Dent, Ricardo, Forbes, Carol A., Deshpande, Sohan, Ross, Janine, Kleijnen, Jos, Stroes, Erik S. G.
Published in Journal of the American Heart Association

Ten things to know about ten cardiovascular disease risk factors – 2022

by Bays, Harold E, Agarwala, Anandita, German, Charles, Satish, Priyanka, Iluyomade, Adedapo, Dudum, Ramzi, Thakkar, Aarti, Rifai, Mahmoud Al, Mehta, Anurag, Thobani, Aneesha, Al-Saiegh, Yousif, Nelson, Adam J, Sheth, Samip, Toth, Peter P.
Published in American journal of preventive cardiology

Prevalence of US Adults with Triglycerides ≥ 150 mg/dl: NHANES 2007–2014

by Fan, Wenjun, Philip, Sephy, Granowitz, Craig, Toth, Peter P., Wong, Nathan D.
Published in Cardiology and Therapy

Effect of Evolocumab on Non-High-Density Lipoprotein Cholesterol, Apolipoprotein B, and Lipoprotein(a): A Pooled Analysis of Phase 2 and Phase 3 Studies

by Toth, Peter P, Jones, Steven R, Monsalvo, Maria Laura, Elliott-Davey, Mary, López, J Antonio G, Banach, Maciej
Published in Journal of the American Heart Association